Significantly reduced expression of PCNA was observed in the tumour sections from mice that were treated with 12.5 mg/kg escitalopram oxalate relative to those that were treated with PBS or 2.5 mg/kg escitalopram oxalate (Fig. 7C). Here, PCNA is linked to neoplasm.